Elegen is a biotechnology company specializing in innovative cell-free DNA synthesis technology, offering ENFINIA DNA, which provides rapid, high-accuracy, long, and complex linear DNA synthesis. Their proprietary technology allows for the production of DNA up to 7 kb in length with an error rate as low as 1:70,000 bp, significantly streamlining workflows in synthetic biology and gene therapy. Elegen's products are designed to eliminate the need for cloning, saving time and costs in various applications, including mRNA vaccine development and biomanufacturing. With a recent $35 million Series B funding round, Elegen is positioned for growth in clinical manufacturing and aims to advance the bioeconomy through innovative DNA manufacturing processes.

San Francisco, CA, USA

San Carlos, CA, USA

Elegen

KdT Ventures is a new age seed stage venture firm, with a focus on the intersection of technology and science.

KdT Ventures LLC

KdT Ventures

Discover available job opportunities within our portfolio

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining KdT Ventures Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the KdT Ventures network as they come up.

You can always update this information later.

Welcome to the KdT Ventures talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a KdT Ventures company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Join Us